The global transplantation market size was valued at USD 17.75 billion in 2025 and is projected to grow from USD 19.45 billion in 2026 to USD 40.34 billion by 2034, registering a CAGR of 9.55% during the forecast period from 2026 to 2034. North America dominated the transplantation market with a market share of 38.5% in 2025.
Transplantation is a medical procedure in which an organ, tissue, or cells are transferred from a donor to a recipient to replace damaged or failing body parts. Common types include kidney, liver, heart, lung, and stem cell transplantation.
Download a Free Sample To learn more about this report,
Growing Organ Transplant Activity
The transplantation market is witnessing increasing activity as healthcare systems work to expand access to lifesaving organ and tissue procedures. According to WHO data, 172,397 solid organ transplants were recorded globally in 2024, representing a 9.5% increase from 2022. However, transplantation activity still meets less than 10% of global needs, highlighting the significant gap between organ demand and availability.
Advances in Xenotransplantation
Xenotransplantation is emerging as a potential solution to the shortage of human donor organs. Researchers are using genetic engineering and improved immunosuppression approaches to investigate whether organs from genetically modified animals can be safely transplanted into humans. The FDA continues to develop regulatory guidance for xenotransplantation as research progresses.
The transplantation market is being driven by the growing need for lifesaving organ and tissue replacement procedures and improvements in transplant care. Advances in donor screening, organ preservation, surgical techniques, and immunosuppressive therapies are helping improve transplant outcomes. Growing healthcare infrastructure and increasing awareness of organ donation are also supporting transplantation activity worldwide.
The limited availability of suitable donor organs remains a major restraint for the transplantation market. Patients may spend extended periods on waiting lists, while differences in donation systems, healthcare infrastructure, and access to specialized transplant centers can further limit transplantation activity. Long-term immunosuppressive treatment can also create additional clinical challenges for recipients.
Xenotransplantation, regenerative medicine, and improved organ preservation technologies are creating new opportunities for the transplantation market. Genetically modified animal organs could potentially provide an additional source of organs, while advances in cell and tissue engineering may support new approaches to replacing or repairing damaged tissues. Improvements in preservation and matching technologies could also help increase the number of organs suitable for transplantation.
Organ rejection, infection risks, complex surgical procedures, and the need for lifelong monitoring remain key challenges in the transplantation market. Xenotransplantation introduces additional concerns, including immune compatibility and the potential transmission of infectious agents from animals to humans. Manufacturers, researchers, and healthcare providers must therefore demonstrate safety and long-term effectiveness while meeting strict regulatory requirements.
Immunosuppressive drugs dominated the transplantation market with a 54.7% share in 2025, reaching USD 9.71 billion, and are projected to grow at a CAGR of 9.18% during 2026–2034. Their leading position is supported by the need to prevent organ rejection following transplantation. As the number of transplant procedures increases, demand for medicines that help patients maintain graft function and manage immune responses is also rising.
Tissue products accounted for 31.4% of the market in 2025, valued at USD 5.57 billion, and are projected to grow at a CAGR of 9.76%. Preservation solutions represented 13.9%, reaching USD 2.47 billion, and are expected to grow at a CAGR of 10.12%. These products are important for maintaining the quality and viability of organs and tissues before transplantation, while improvements in preservation techniques are supporting their adoption.
Request Customizationto receive a tailored report.
Organ transplantation dominated the application segment with a 68.3% share in 2025, reaching USD 12.12 billion, and is projected to grow at a CAGR of 9.31% during 2026–2034. The segment includes procedures involving organs such as kidneys, liver, heart, lungs, and other vital organs. Growing demand for lifesaving procedures, improvements in transplant surgery, and better post-transplant care are supporting this segment.
Tissue transplantation accounted for 31.7% of the market in 2025, valued at USD 5.63 billion, and is projected to grow at the fastest CAGR of 9.68%. The segment includes transplantation of tissues used in reconstructive, orthopedic, ophthalmic, and other medical procedures. Increasing use of tissue-based treatments and improvements in tissue preservation and processing are supporting its growth.
Hospitals dominated the end-user segment with a 49.6% share in 2025, reaching USD 8.80 billion, and are projected to grow at a CAGR of 9.22% during 2026–2034. Hospitals remain major points of care for transplantation because they provide specialized surgical facilities, intensive care, diagnostic services, and long-term patient monitoring. Growing investment in advanced healthcare infrastructure is supporting their role in transplant procedures.
Transplant centers accounted for 38.1% of the market in 2025, valued at USD 6.76 billion, and are projected to grow at a CAGR of 9.84%. These specialized facilities provide multidisciplinary transplant services, including donor assessment, organ matching, surgery, immunosuppression management, and follow-up care. Other end users accounted for 12.3% of the market, reaching USD 2.18 billion, with a projected CAGR of 8.91%.
Speak to an Analystto discuss market opportunities.
North America dominated the transplantation market with a 38.5% share in 2025, reaching USD 6.83 billion, and is projected to grow at a CAGR of 8.95% during 2026–2034. The region's strong position is supported by advanced transplant infrastructure, specialized healthcare facilities, organ donation programs, and increasing adoption of advanced transplant procedures.
The US market is supported by its advanced healthcare infrastructure, large network of transplant centers, organ donation programs, and growing investment in transplantation research and technologies.
Canada's market is supported by established organ donation systems, specialized transplant centers, and increasing demand for kidney, liver, heart, and other organ transplantation procedures.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe accounted for 27.2% of the transplantation market in 2025, reaching USD 4.83 billion, and is projected to grow at a CAGR of 8.74% during 2026–2034. Growth is supported by improvements in transplant infrastructure, organ donation initiatives, advanced surgical techniques, and increasing healthcare expenditure.
The UK market is supported by established organ donation programs, specialized transplant centers, and improvements in transplantation procedures and post-transplant patient care.
Germany's market benefits from its advanced healthcare infrastructure, specialized hospitals, transplant centers, and growing adoption of modern surgical and organ preservation technologies.
Asia Pacific accounted for 22.6% of the transplantation market in 2025, reaching USD 4.01 billion, and is projected to grow at the fastest CAGR of 10.86% during 2026–2034. Rising healthcare investment, improving transplant infrastructure, growing awareness of organ donation, and increasing demand for transplantation procedures are supporting regional expansion.
Japan's market is supported by advanced medical technology, specialized healthcare facilities, improvements in transplant procedures, and increasing investment in regenerative medicine and organ preservation.
China's market benefits from its large patient population, expanding healthcare infrastructure, increasing transplant capacity, and improvements in organ donation and transplantation systems.
Middle East and Africa accounted for 4.9% of the transplantation market in 2025, reaching USD 0.87 billion, and is projected to grow at a CAGR of 8.52% during 2026–2034. Growth is supported by healthcare infrastructure development, increasing investment in specialized medical facilities, and growing demand for advanced transplantation services.
The UAE market is supported by investments in advanced healthcare infrastructure, specialized transplant services, and medical centers offering complex organ transplantation procedures.
Africa's market is supported by improving healthcare infrastructure, increasing awareness of organ donation, and gradual development of specialized transplant centers and transplantation services.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Healthcare Finance Solutions Market Size, Share, Growth, 2034
Medical Packaging Market Size, Share, Growth, Opportunities, Analysis, 2034
Regulatory Affairs Outsourcing Market Size, Share, Growth, 2034
Small Molecule Drug Discovery Market Size, Share, Growth, 2034
Single-Use Medical Device Reprocessing Market Size, Share, 2034
Pharmaceutical R&D Outsourcing Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com